131 related articles for article (PubMed ID: 28930560)
1. Structural and molecular biology of PSP94: Its significance in prostate pathophysiology.
Anklesaria JH; Mhatre DR; Mahale SD
Front Biosci (Landmark Ed); 2018 Jan; 23(3):535-562. PubMed ID: 28930560
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition properties of the putative prostate cancer biomarkers PSP94 and CRISP-3.
Van Eynde A; Litovkin K; Bollen M
Asian J Androl; 2011 Mar; 13(2):205-6. PubMed ID: 21102472
[No Abstract] [Full Text] [Related]
3. Molecular cloning and gene expression analysis of PSP94 (prostate secretory protein of 94 amino acids) in primates.
Xuan JW; Wu D; Guo Y; Garde S; Shum DT; Mbikay M; Zhong R; Chin JL
DNA Cell Biol; 1997 May; 16(5):627-38. PubMed ID: 9174167
[TBL] [Abstract][Full Text] [Related]
4. Expression study of three secretory proteins (prostatic secretory protein of 94 amino acids, probasin, and seminal vesicle secretion II) in dysplastic and neoplastic rat prostates.
Kwong J; Lui K; Chan PS; Ho SM; Wong YC; Xuan JW; Chan FL
Prostate; 2003 Jul; 56(2):81-97. PubMed ID: 12746832
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition mediated by PSP94 or CRISP-3 is prostate cancer cell line specific.
Pathak BR; Breed AA; Nakhawa VH; Jagtap DD; Mahale SD
Asian J Androl; 2010 Sep; 12(5):677-89. PubMed ID: 20676114
[TBL] [Abstract][Full Text] [Related]
6. Prostate Secretory Protein of 94 amino acids (PSP94) binds to prostatic acid phosphatase (PAP) in human seminal plasma.
Anklesaria JH; Jagtap DD; Pathak BR; Kadam KM; Joseph S; Mahale SD
PLoS One; 2013; 8(3):e58631. PubMed ID: 23469287
[TBL] [Abstract][Full Text] [Related]
7. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
[TBL] [Abstract][Full Text] [Related]
8. Identification, purification and characterization of a novel human blood protein with binding affinity for prostate secretory protein of 94 amino acids.
Reeves JR; Xuan JW; Arfanis K; Morin C; Garde SV; Ruiz MT; Wisniewski J; Panchal C; Tanner JE
Biochem J; 2005 Jan; 385(Pt 1):105-14. PubMed ID: 15344909
[TBL] [Abstract][Full Text] [Related]
9. Prostate secretory protein 94 inhibits sterol binding and export by the mammalian CAP protein CRISP2 in a calcium-sensitive manner.
El Atab O; Kocabey AE; Asojo OA; Schneiter R
J Biol Chem; 2022 Mar; 298(3):101600. PubMed ID: 35063506
[TBL] [Abstract][Full Text] [Related]
10. The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2.
Beke L; Nuytten M; Van Eynde A; Beullens M; Bollen M
Oncogene; 2007 Jul; 26(31):4590-5. PubMed ID: 17237810
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of prostate secretory protein PSP94 shows an edge-to-edge association of two monomers to form a homodimer.
Kumar A; Jagtap DD; Mahale SD; Kumar M
J Mol Biol; 2010 Apr; 397(4):947-56. PubMed ID: 20184897
[TBL] [Abstract][Full Text] [Related]
12. Serum bound forms of PSP94 (prostate secretory protein of 94 amino acids) in prostate cancer patients.
Wu D; Guo Y; Chambers AF; Izawa JI; Chin JL; Xuan JW
J Cell Biochem; 1999 Nov; 76(1):71-83. PubMed ID: 10581002
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of CRISP-3 from human seminal plasma and its real-time binding kinetics with PSP94.
Anklesaria JH; Pandya RR; Pathak BR; Mahale SD
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1039():59-65. PubMed ID: 27825912
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of hormonal regulation of three secretory proteins (prostatic secretory protein-PSP94, probasin, and seminal vesicle secretion II) in rat lateral prostate.
Kwong J; Xuan JW; Chan PS; Ho SM; Chan FL
Endocrinology; 2000 Dec; 141(12):4543-51. PubMed ID: 11108266
[TBL] [Abstract][Full Text] [Related]
15. Mouse PSP94 expression is prostate tissue-specific as demonstrated by a comparison of multiple antibodies against recombinant proteins.
Thota A; Karajgikar M; Duan W; Gabril MY; Chan FL; Wong YC; Sakai H; Chin JL; Moussa M; Xuan JW
J Cell Biochem; 2003 Apr; 88(5):999-1011. PubMed ID: 12616537
[TBL] [Abstract][Full Text] [Related]
16. The potential use of prostatic secretory protein of 94 amino acid residues (PSP94) as a serum marker for prostatic tumor.
von der Kammer H; Jurincic-Winkler C; Horlbeck R; Klippel KF; Pixberg HU; Scheit KH
Urol Res; 1993 May; 21(3):227-33. PubMed ID: 7688168
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a serum tumor marker for preclinical trials of mouse prostate cancer models.
Huizen IV; Wu G; Moussa M; Chin JL; Fenster A; Lacefield JC; Sakai H; Greenberg NM; Xuan JW
Clin Cancer Res; 2005 Nov; 11(21):7911-9. PubMed ID: 16278416
[TBL] [Abstract][Full Text] [Related]
18. PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancer.
Imasato Y; Xuan JW; Sakai H; Izawa JI; Saito Y; Chin JL; Moussa M
J Urol; 2000 Nov; 164(5):1819-24. PubMed ID: 11025776
[TBL] [Abstract][Full Text] [Related]
19. Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.
Bergström SH; Järemo H; Nilsson M; Adamo HH; Bergh A
Prostate; 2018 Mar; 78(4):257-265. PubMed ID: 29250809
[TBL] [Abstract][Full Text] [Related]
20. In situ hybridization study of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostates.
Chan PS; Chan LW; Xuan JW; Chin JL; Choi HL; Chan FL
Prostate; 1999 Oct; 41(2):99-109. PubMed ID: 10477906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
